Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme

Eur J Med Chem. 2022 Dec 5:243:114730. doi: 10.1016/j.ejmech.2022.114730. Epub 2022 Sep 1.

Abstract

The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative.

Keywords: Enantiopure 4-amino-3,4-dihydrocoumarins; Glioblastoma multiforme; N-sulfinylarylimines; β-hydroxyesters.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Esters / chemistry
  • Esters / pharmacology
  • Glioblastoma* / drug therapy
  • Humans
  • Stereoisomerism

Substances

  • ethyl acetate
  • Esters
  • Antineoplastic Agents